Do Older Men With Prostate Cancer Benefit From Addition of ADT to Radiation Therapy?
A study presented at the American Society for Radiation Oncology (ASTRO) 2024 Annual Meeting in Washington, DC, investigated the potential survival benefit associated with the addition of androgen deprivation therapy (ADT) to radiation therapy (RT) in older patients with prostate cancer. Dr. Timothy Dougherty and colleagues from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, compared the risk of mortality among patients with intermediate-risk prostate cancer who were age 60 or older. Overall, 10,168 men received RT plus ADT and 12,396 received RT alone. A larger proportion of men in the RT plus ADT group had Gleason 4+3 ...
Advertisement
Advertisement
Advertisement

Expert Interviews

Urban Health Weekly

Featured Knowledge Hubs

AI in Medicine

Network Websites

Powered by DocWire News